PubMed ID:
26831744
Public Release Type:
Journal
Publication Year: 2016
Affiliation: Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, PA.
DOI:
https://doi.org/10.1016/j.jpeds.2015.12.079
Authors:
Alexander S,
Al-Uzri A,
Andreoli S,
Atkinson M,
Bartosh S,
Benador N,
Blydt-Hansen T,
Brophy P,
Cai Y,
Chronic Kidney Disease in Children (CKiD) Study,
Dart A,
Davis K,
Dell KM,
Fathallah S,
Ferris M,
Flynn J,
Furth SL,
Gipson D,
Goebel J,
Greenbaum L,
Harmon W,
Hartung EA,
Hastings C,
Hidalgo G,
Jenkins R,
Jenkins R,
Jenkins R,
John E,
Kaskel F,
Kher K,
Kupferman J,
Lande M,
Langman C,
Lerner G,
Mak R,
Massengill S,
Matheson M,
Matoo T,
Mattosian D,
Mendley S,
Mitsnefes M,
Morgenstern B,
Muñoz A,
Norwood V,
Pan C,
Parekh R,
Patel H,
Portale A,
Robinson L,
Rodig N,
Saland J,
Salusky I,
Samsonov D,
Samuels J,
Schwartz G,
Seikaly M,
Seo-Mayer P,
Srivaths P,
Turman M,
Upadhyay K,
Warady BA,
Weiss L,
Wong C,
Wong C,
Wood E,
Yadin O
Studies:
The Chronic Kidney Disease in Children Cohort Study
To define glomerular filtration rate (GFR) decline, hypertension (HTN), and proteinuria in subjects with autosomal recessive polycystic kidney disease (ARPKD) and compare with 2 congenital kidney disease control groups in the Chronic Kidney Disease in Children cohort.